30.06.2015 18:00:00
|
SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s Second-Largest Spine Market: China
Regulatory News:
Spineguard (Paris:ALSGD) (FR0011464452 – ALSGD) announced today that it has received regulatory clearance to market its Classic PediGuard® products in China.
"This regulatory clearance is the result of a diligent collaborative process with General Care International (GCI),” said Pierre Jérôme, Co-founder and Chief Executive Officer of SpineGuard. "It is a major milestone for SpineGuard and further validates the value of our DSG™ (Dynamic Surgical Guidance)-based PediGuard device for making spine surgery safer.”
The China spine market has become the second-largest market in spine after the USA and is projected to be worth over $1 billion by 2019 according to IData Research, driven by an ageing population, increasing disease, improving treatment rate and growing affordability. "The number of spine fusions is growing rapidly across China, and I believe there is a strong need for a simple smart device like PediGuard consistently ensuring safe and accurate placement of pedicle screws,” added Professor Yong Qiu, Chief Spinal Surgeon at the Nanjing University Hospital.
About SpineGuard®
Co-founded in 2009 in France and the USA
by Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make
spine surgery safer. Its primary objective is to establish its
proprietary Dynamic Surgical Guidance (DSG™) technology as the global
standard of surgical care, initially for safer screw placement in spine
surgery and then in other surgeries. PediGuard®, the first device
designed using DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran
Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is
the world’s first and only handheld device capable of alerting surgeons
to potential pedicular or vertebral breaches. Close to 40,000 surgical
procedures have been performed worldwide with PediGuard. Numerous
studies published in peer-reviewed medical and scientific journals have
demonstrated the multiple benefits that PediGuard delivers to patients,
surgical staff and hospitals. In 2015 SpineGuard started to expand the
applications of DSG into pedicle screws through partnerships with
innovative surgical companies in France and the US. SpineGuard has
offices in San Francisco and Paris. For further information, visit www.spineguard.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150630005770/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Spineguardmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Spineguardmehr Analysen
Aktien in diesem Artikel
Spineguard | 0,16 | 1,91% |